(19)
(11) EP 4 319 736 A1

(12)

(43) Date of publication:
14.02.2024 Bulletin 2024/07

(21) Application number: 22785065.8

(22) Date of filing: 08.04.2022
(51) International Patent Classification (IPC): 
A61K 31/282(2006.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
A61K 31/337(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/337; A61P 35/00; A61K 45/06; C07K 16/2818; A61K 2039/505; A61K 2039/545; A61K 39/3955; C07K 16/22; A61K 2039/507; A61K 33/243; A61K 31/555
 
C-Sets:
  1. A61K 39/3955, A61K 2300/00;
  2. A61K 33/243, A61K 2300/00;
  3. A61K 31/337, A61K 2300/00;
  4. A61K 31/555, A61K 2300/00;

(86) International application number:
PCT/RU2022/050122
(87) International publication number:
WO 2022/216184 (13.10.2022 Gazette 2022/41)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.04.2021 RU 2021109765

(71) Applicant: Joint Stock Company "Biocad"
St. Petersburg 198515 (RU)

(72) Inventors:
  • SHUSTOVA, Mariia Stanislavovna
    Saint Petersburg, 196135 (RU)
  • FOGT, Sergei Nikolaevich
    Saint Petersburg, 197372 (RU)
  • KRYUKOV, Fedor Borisovich
    Saint Petersburg, 192076 (RU)
  • MOROZOV, Dmitry Valentinovich
    Saint Petersburg, 190000 (RU)

(74) Representative: Meissner Bolte Partnerschaft mbB 
Widenmayerstrasse 47
80538 München
80538 München (DE)

   


(54) MALIGNANT NEOPLASIS TREATMENT USING PD-1 ANTIBODY COMBINATION